Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Scheper

Showing results (251-260 of 285) with videos related to

Pageof 29
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2000
Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogsJ Wijnholds, C A Mol, L van Deemter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Differentiation dependent expression of P-glycoprotein in the normal and neoplastic human kidneyC K van Kalken, P van der Valk, M M Hadisaputro, et al.
International Journal of Cancer|February 15, 1989
Immunohistochemical detection of P-glycoprotein in human tumor cells with a low degree of drug resistanceH J Broxterman, H M Pinedo, C M Kuiper, et al.
The Journal of Clinical Investigation|February 17, 2000
Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrierJ Wijnholds, E C deLange, G L Scheffer, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Major histocompatibility complex class II antigen expression during potentiation of line-10 tumor immunity after intralesional administration of bacillus Calmette-GuérinP A Steerenberg, W H De Jong, E Geerse, et al.
The American Journal of Pathology|April 1, 1996
Tissue distribution of the multidrug resistance proteinM J Flens, G J Zaman, P van der Valk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteinsB E Plaat, H Hollema, W M Molenaar, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1999
A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCAQ Waisfisz, J P de Winter, F A Kruyt, et al.
Blood|March 15, 1996
Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemiaA F List, C S Spier, T M Grogan, et al.
British Journal of Cancer|January 1, 1997
The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancerK Nooter, G Brutel de la Riviere, M P Look, et al.
Pageof 29

Showing results (251-260 of 285) with videos related to

Sort By:
Pageof 29
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2000
Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogsJ Wijnholds, C A Mol, L van Deemter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Differentiation dependent expression of P-glycoprotein in the normal and neoplastic human kidneyC K van Kalken, P van der Valk, M M Hadisaputro, et al.
International Journal of Cancer|February 15, 1989
Immunohistochemical detection of P-glycoprotein in human tumor cells with a low degree of drug resistanceH J Broxterman, H M Pinedo, C M Kuiper, et al.
The Journal of Clinical Investigation|February 17, 2000
Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrierJ Wijnholds, E C deLange, G L Scheffer, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Major histocompatibility complex class II antigen expression during potentiation of line-10 tumor immunity after intralesional administration of bacillus Calmette-GuérinP A Steerenberg, W H De Jong, E Geerse, et al.
The American Journal of Pathology|April 1, 1996
Tissue distribution of the multidrug resistance proteinM J Flens, G J Zaman, P van der Valk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteinsB E Plaat, H Hollema, W M Molenaar, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1999
A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCAQ Waisfisz, J P de Winter, F A Kruyt, et al.
Blood|March 15, 1996
Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemiaA F List, C S Spier, T M Grogan, et al.
British Journal of Cancer|January 1, 1997
The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancerK Nooter, G Brutel de la Riviere, M P Look, et al.
Pageof 29